OKYO Stock Price | OKYO Pharma Ltd ADR P/E, Revenue, EPS, & Forecasts

OKYO Pharma Ltd ADR • OKYO

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About OKYO Pharma Ltd ADR

Ticker

OKYO

Trading on

NASDAQ

ISIN

US6793451088

Industry

Biotechnology

Sector

Healthcare

CEO

Dr. Gary S. Jacob Ph.D.

Headquarters

14/15 Conduit St, London, undefined, United Kingdom, W1S 2XJ

Employees

Website

https://okyopharma.com

OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead clinical product candidate is urcosimod, which is in Phase II clinical trials for the treatment of dry eye disease; in Phase II clinical trial to treat neuropathic corneal pain; and is in preclinical trial to treat allergic conjunctivitis and uveitis. The company is also developing OK-201 for the treatment acute and chronic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

Metrics

BasicAdvanced

Market cap

$97.8M

P/E ratio

EPS

-$0.12

Dividend Yield

0.00%

Beta

-0.18

Forward P/E ratio

EBIDTA

$-7.1M

Ex dividend date

Price & volume

Market cap

$97.8M

Average daily volume

0.1M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

14.11

Earnings

EPS

-$0.12

EPS estimate (current quarter)

-$0.02

EPS estimate (next quarter)

-$0.02

EBITDA

$-7.1M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

-0.18

52-week High

$3.35

52-week Low

$0.90

50-day moving average

$2.26

200-day moving average

$1.96

Short ratio

0.02

Short %

0.02%

Management effectiveness

ROE (TTM)

-2,968.51%

ROA (TTM)

-169.87%

Profit margin

0.00%

Gross profit margin

$-4.8M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

37.6M

Float

23.2M

Insiders %

38.44%

Institutions %

7.37%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 1 analysts.

Average price target

$10.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.09

Q3 • 24Beat

-$0.08

-$0.09

11.11%

Q4 • 24Beat

-$0.05

Q1 • 25Beat

-$0.06

-$0.05

-20.00%

Q2 • 25Missed

-$0.04

Q3 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$-2M

0.00%

Q1 • 25

$-2M

0.00%

Q2 • 25

NaN%

-0.00%

0.00%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$3.7M

$9.2M

250.91%

Q1 • 25

$3.7M

$9.2M

250.91%

Q2 • 25

0.00%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-1.6M

$2.1M

$-1.6M

Q1 • 25

$-1.6M

$2.1M

$-1.6M

Q2 • 25

-0.05%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a OKYO Pharma Ltd ADR share?

OKYO Pharma Ltd ADR shares are currently traded for undefined per share.

How many shares does OKYO Pharma Ltd ADR have?

OKYO Pharma Ltd ADR currently has 37.6M shares.

Does OKYO Pharma Ltd ADR pay dividends?

No, OKYO Pharma Ltd ADR doesn't pay dividends.

What is OKYO Pharma Ltd ADR 52 week high?

OKYO Pharma Ltd ADR 52 week high is $3.35.

What is OKYO Pharma Ltd ADR 52 week low?

OKYO Pharma Ltd ADR 52 week low is $0.90.

What is the 200-day moving average of OKYO Pharma Ltd ADR?

OKYO Pharma Ltd ADR 200-day moving average is $1.96.

Who is OKYO Pharma Ltd ADR CEO?

The CEO of OKYO Pharma Ltd ADR is Dr. Gary S. Jacob Ph.D..

How many employees OKYO Pharma Ltd ADR has?

OKYO Pharma Ltd ADR has 4 employees.

What is the market cap of OKYO Pharma Ltd ADR?

The market cap of OKYO Pharma Ltd ADR is $97.8M.

What is the P/E of OKYO Pharma Ltd ADR?

The current P/E of OKYO Pharma Ltd ADR is null.

What is the EPS of OKYO Pharma Ltd ADR?

The EPS of OKYO Pharma Ltd ADR is -$0.12.

What is the PEG Ratio of OKYO Pharma Ltd ADR?

The PEG Ratio of OKYO Pharma Ltd ADR is null.

What do analysts say about OKYO Pharma Ltd ADR?

According to the analysts OKYO Pharma Ltd ADR is considered a buy.